Indeed, ErbB2 has been identified as an oncogene [34], and anti-ErbB2 antibody has been used as an anti-tumor drug [35], [36], although ErbB3 is not identified as an oncogene because it may lack enzyme activity. This evidence concerns the gene ERBB3 and neoplasm.